Anti-SLC35D2 monoclonal antibody

Pre-made anti-SLC35D2 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SLC35D2/SLC35D2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP1712-Ab-1/ GM-Tg-hg-IP1712-Ab-2Anti-Human SLC35D2 monoclonal antibodyHuman
GM-Tg-rg-IP1712-Ab-1/ GM-Tg-rg-IP1712-Ab-2Anti-Rat SLC35D2 monoclonal antibodyRat
GM-Tg-mg-IP1712-Ab-1/ GM-Tg-mg-IP1712-Ab-2Anti-Mouse SLC35D2 monoclonal antibodyMouse
GM-Tg-cynog-IP1712-Ab-1/ GM-Tg-cynog-IP1712-Ab-2Anti-Cynomolgus/ Rhesus macaque SLC35D2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP1712-Ab-1/ GM-Tg-felg-IP1712-Ab-2Anti-Feline SLC35D2 monoclonal antibodyFeline
GM-Tg-cang-IP1712-Ab-1/ GM-Tg-cang-IP1712-Ab-2Anti-Canine SLC35D2 monoclonal antibodyCanine
GM-Tg-bovg-IP1712-Ab-1/ GM-Tg-bovg-IP1712-Ab-2Anti-Bovine SLC35D2 monoclonal antibodyBovine
GM-Tg-equg-IP1712-Ab-1/ GM-Tg-equg-IP1712-Ab-2Anti-Equine SLC35D2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP1712-Ab-1/ GM-Tg-hg-IP1712-Ab-2; GM-Tg-rg-IP1712-Ab-1/ GM-Tg-rg-IP1712-Ab-2;
GM-Tg-mg-IP1712-Ab-1/ GM-Tg-mg-IP1712-Ab-2; GM-Tg-cynog-IP1712-Ab-1/ GM-Tg-cynog-IP1712-Ab-2;
GM-Tg-felg-IP1712-Ab-1/ GM-Tg-felg-IP1712-Ab-2; GM-Tg-cang-IP1712-Ab-1/ GM-Tg-cang-IP1712-Ab-2;
GM-Tg-bovg-IP1712-Ab-1/ GM-Tg-bovg-IP1712-Ab-2; GM-Tg-equg-IP1712-Ab-1/ GM-Tg-equg-IP1712-Ab-2
Products NameAnti-SLC35D2 monoclonal antibody
Formatmab
Target NameSLC35D2
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SLC35D2 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP1712-Ag-1Recombinant multi-species S35D2/ SLC35D2/ HFRC1 protein


    Target information

    Target IDGM-IP1712
    Target NameSLC35D2
    Gene ID11046,70484,290959,719257,100856233,101089404,617113,100062655
    Gene Symbol and Synonyms5730408I21Rik,hfrc,HFRC1,mUGTrel8,SLC35D2,SQV7L,UGTrel8
    Uniprot AccessionQ76EJ3
    Uniprot Entry NameS35D2_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000130958
    Target ClassificationN/A

    The target: SLC35D2, gene name: SLC35D2, also named as HFRC1, SQV7L, UGTrel8, hfrc. Nucleotide sugars, which are synthesized in the cytosol or the nucleus, are high-energy donor substrates for glycosyltransferases located in the lumen of the endoplasmic reticulum and Golgi apparatus. Translocation of nucleotide sugars from the cytosol into the lumen compartment is mediated by specific nucleotide sugar transporters, such as SLC35D2 (Suda et al., 2004 [PubMed 15082721]).[supplied by OMIM, Mar 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.